A 37-year-old man with Stage 4 melanoma in Ontario has won a legal battle to obtain provincial coverage for cancer treatment abroad after an initial denial. Alex Shved, seeking tumour-infiltrating lymphocyte therapy in the United States, faced resistance from the Ontario Health Insurance Plan. However, a recent ruling by the Divisional Court overturned the decision and mandated OHIP to provide a new verdict within a week.
The court emphasized the life-or-death urgency of the situation for Shved, criticizing OHIP’s reasoning as “problematic” for denying coverage. While OHIP cited concerns about jeopardizing future negotiations with drug manufacturers for public funding in Ontario, the judges found this rationale lacking a solid foundation.
In a split verdict, two judges condemned OHIP’s denial, urging a swift resolution for Shved’s critical medical needs. The dissenting judge, while agreeing with the majority, urged OHIP to expedite a funding recommendation from the executive officer of Ontario public drug programs.
